All Articles

As AI agents gain the power to act, a new class of risk emerges. Molt AI's Fisher aims to expose what agents do, not just what they say.

Docufree's 743-spot leap on the Inc. 5000 list isn't just about growth. It's about a critical shift toward trusted, AI-ready data as the new foundation for enterprise AI.

While others chase fleeting trends, Cargojet's 24-year ISO 9001 certification reveals a deep moat of operational excellence. Here's the why.

A new partnership between Dumpsters.com and Blue Point Capital aims to transform the $100B waste industry with an asset-light tech platform and big capital.

Amid market volatility, Ability Insurance's new guaranteed annuities offer a safe haven, but how does their B+ rating stack up in a competitive field?

A major alliance of urban schools is reframing the lunch line as the front line of preventive healthcare, appointing a doctor to tackle childhood disease.

Alto's new Private Deal Room gives advisors a streamlined path to private deals, aiming to unlock a massive, untapped pool of retirement funds for clients.

Oshkosh Defense and the Marines are testing a radical new logistics model: printing critical parts on-demand. Is this the end of vulnerable supply chains?

Clearwave's new 'agentic workforce' automates the entire patient journey. It promises massive efficiency gains, but what is the human cost and benefit?

Haoxi Health announces a second reverse split in three months, a move to save its Nasdaq listing that investors see as a red flag, despite its strategic AI push.

A new study shows 98% success for Mendaera's handheld robot. Beyond the launch, can this device truly bridge the gap in specialized medical skills?

As HSDT prepares to report Q2 results, investors are watching closely. Is its unique strategy of tying shareholder value directly to the Solana ecosystem paying off?

A new report reveals a $1.4 trillion threat to U.S. homes, exposing a hidden danger: fires spreading from house to house, not just from the wild.

With its third Inc. 5000 win, Thoropass’s AI-native platform proves that automation is the future for navigating complex cybersecurity compliance.

With a cash runway into 2029, Avalyn Pharma is advancing a novel inhaled drug platform, hitting key clinical milestones to challenge an oral-dominated market.

On World Elephant Day, a campaign to free an elephant named Joyce from Six Flags ignites a fierce debate on ethics, activism, and corporate responsibility.

With Coco Gauff and Taylor Fritz, ŌURA isn't just selling a smart ring. It's selling a new philosophy of athletic success built on data, recovery, and story.

A boutique bank just handed over a 50% stake to two star tech bankers. It's more than a hire; it's a strategic reset signaling a new model for Wall Street.

A new alliance is betting big on resurrecting 3D TV by ditching the glasses. We analyze if their advanced tech can finally make immersive viewing a shared reality.

A shocking new report finds only 5% of employees use GenAI effectively. The key isn't the tool, but the human skill and governance behind it.